Lysosomal storage diseases in North America: a comprehensive review of enzyme therapies and unmet needs. [PDF]
Bennett LL.
europepmc +1 more source
Characterization of gallbladder disease in metachromatic leukodystrophy across the lifespan. [PDF]
Mutua S +8 more
europepmc +1 more source
Development, validation and application of single molecule molecular inversion probe based novel integrated genetic screening method for 29 common lysosomal storage disorders in India. [PDF]
Sheth H +41 more
europepmc +1 more source
Lentiviral Vector-Mediated <i>Ex Vivo</i> Hematopoietic Stem Cell Gene Therapy for Mucopolysaccharidosis IVA Murine Model. [PDF]
Celik B +5 more
europepmc +1 more source
Cerebroside sulfatase determination in cultured human fibroblasts
A procedure for the determination of cerebroside sulfatase activity in extracts of cultured human fibroblasts is described. Cerebroside [35S]sulfate prepared from developing rat brain serves as substrate and enzyme activity is estimated by measurement of released inorganic [35S]sulfate.
M T, Porter +3 more
core +4 more sources
Metachromatic leukodystrophy caused by a partial cerebroside sulfatase defect
A patient with neuropathy and myopathy since infancy but whose neuropathy had been stable for a number of years showed a profound deficiency of arylsulfatase A in leukocytes and urine. Urine contained material that stained metachromatically and cochromatographed with cerebroside sulfate.
H, Kihara +3 more
core +4 more sources
Late-onset Krabbe disease initially diagnosed as cerebroside sulfatase activator deficiency
Clinical and biochemical findings in a male subject with progressive encephalopathy and peripheral neuropathy are presented. Early development was normal. At age 3.5 years, he had seizures associated with fever. Subsequently, there was progressive neurologic deterioration. A CT brain scan at age 4 years, 2 months demonstrated multiple areas of variable
A L, Fluharty +3 more
core +4 more sources
Several cases of metachromatic leukodystrophy (MLD) have been described with normal or near normal activities of arylsulfatase A (cerebroside sulfatase). However, the ability of intact cultured fibroblasts to hydrolyze cerebroside sulfate was impaired. Since the impairment was corrected by cerebroside sulfatase activator, a deficiency of activator was ...
H, Kihara, K K, Tsay, A L, Fluharty
core +4 more sources
Abstract A convenient method for large scale preparation of stearoyl[1- 14 C]sulfogalactosylsphingosine has been developed. The first step consists in preparing the lysosulfatide intermediate with a good yield, which we have successfully performed. In the second step, the lysoderivative is coupled to [1- 14 C]stearic acid through the acyl chloride ...
G, Dubois +3 more
core +4 more sources
The Specificity of Cerebroside Sulfatase Activator
The unability for the lysosomal lipid hydrolases to act on their natural substrate alone, has been reported a long time ago (1). They showed the necessity to add a “detergent-like” natural protein called activator protein which allows the hydrolysis of the sulfatides by cerebroside sulfatase.
Gisèle Dubois +2 more
core +3 more sources

